Novel processes for makingand a new crystalline form ofleflunomide

Details for Australian Patent Application No. 2005202109 (hide)

Owner Teva Pharmaceutical Industries Ltd.

Inventors Avrutov, Ilya; Aronhime, Judith; Gershon, Neomi

Agent Shelston IP

Pub. Number AU-A-2005202109

Parent 779931

Filing date 17 May 2005

Wipo publication date 9 June 2005

International Classifications

A61K 031/42 - Oxazoles

C07D 261/14 Heterocyclic compounds having nitrogen and oxygen as the only ring hetero atoms

C07D 261/12 Heterocyclic compounds having nitrogen and oxygen as the only ring hetero atoms

C07D 261/10 Heterocyclic compounds having nitrogen and oxygen as the only ring hetero atoms

A61P 019/02 Drugs for skeletal disorders

Event Publications

2 June 2005 Complete Application Filed

9 June 2005 Application Open to Public Inspection

  Published as AU-A-2005202109

22 December 2005 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005202110-Shaft pit equipment for a lift

2005202108-Compositions and methods for modifying soil and applications therefor